JuiChing Chen - Oneness Biotech Director Department
| 4743 Stock | TWD 101.50 3.50 3.33% |
Insider
JuiChing Chen is Director Department of Oneness Biotech Co
| Phone | 886 2 2703 1098 |
| Web | https://www.onenessbio.com |
Oneness Biotech Management Efficiency
Oneness Biotech's management efficiency ratios could be used to measure how well Oneness Biotech manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| K Lin | Tanvex BioPharma | N/A | |
| Helena Makagiansar | Tanvex BioPharma | N/A | |
| ChengEn Tsai | OBI Pharma | N/A | |
| YuNan Shih | OBI Pharma | N/A | |
| Yun Yen | Tanvex BioPharma | N/A | |
| ShihShen Lee | Medigen Vaccine Biologics | N/A | |
| LungYeh Cho | Tanvex BioPharma | N/A | |
| MingTien Lai | OBI Pharma | N/A | |
| ChungCheng Liu | Adimmune Corp | N/A | |
| ChihHsiang Leng | Adimmune Corp | N/A | |
| Mitchell MS | OBI Pharma | N/A | |
| MBA MD | Adimmune Corp | N/A | |
| Sharon Lee | OBI Pharma | N/A | |
| Hui Zheng | TaiMed Biologics | N/A | |
| Tamon Tseng | Tanvex BioPharma | N/A | |
| TienChieh Lee | TaiMed Biologics | N/A | |
| ChiHsien Chan | Adimmune Corp | N/A | |
| Lily Yuan | Tanvex BioPharma | N/A | |
| Yun Yan | OBI Pharma | N/A | |
| FACP FACP | Tanvex BioPharma | 67 | |
| Linda Grillo | Tanvex BioPharma | N/A | |
Management Performance
| Return On Equity | 0.0788 | |||
| Return On Asset | -0.0068 |
Oneness Biotech Leadership Team
Elected by the shareholders, the Oneness Biotech's board of directors comprises two types of representatives: Oneness Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Oneness. The board's role is to monitor Oneness Biotech's management team and ensure that shareholders' interests are well served. Oneness Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Oneness Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| NienYi Chen, Deputy Division | ||
| MP MD, VP Affairs | ||
| WenTzu Hsiao, Acting Department | ||
| KungMing Lu, Director Center | ||
| ChihHui Cheng, GM Governance | ||
| Debbie Fang, Mang Department | ||
| JuiChing Chen, Director Department |
Oneness Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Oneness Biotech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0788 | |||
| Return On Asset | -0.0068 | |||
| Profit Margin | 1.06 % | |||
| Operating Margin | (0.16) % | |||
| Current Valuation | 92.26 B | |||
| Shares Outstanding | 387.86 M | |||
| Shares Owned By Insiders | 30.64 % | |||
| Shares Owned By Institutions | 14.80 % | |||
| Price To Book | 6.54 X | |||
| Price To Sales | 88.17 X |
Pair Trading with Oneness Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Oneness Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oneness Biotech will appreciate offsetting losses from the drop in the long position's value.Moving together with Oneness Stock
Moving against Oneness Stock
| 0.87 | 2891 | CTBC Financial Holding | PairCorr |
| 0.81 | 2891B | CTBC Financial Holding | PairCorr |
| 0.74 | 2883 | China Development | PairCorr |
| 0.69 | 4162 | PharmaEngine | PairCorr |
| 0.58 | 2330 | Taiwan Semiconductor | PairCorr |
The ability to find closely correlated positions to Oneness Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Oneness Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Oneness Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Oneness Biotech Co to buy it.
The correlation of Oneness Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Oneness Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Oneness Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Oneness Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Oneness Stock Analysis
When running Oneness Biotech's price analysis, check to measure Oneness Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oneness Biotech is operating at the current time. Most of Oneness Biotech's value examination focuses on studying past and present price action to predict the probability of Oneness Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oneness Biotech's price. Additionally, you may evaluate how the addition of Oneness Biotech to your portfolios can decrease your overall portfolio volatility.